OssDsign reaches commercial milestone of 200 implants in France

Uppsala, March 14 2023. OssDsign AB (publ.) today announces that the company has reached the commercial milestone of 200 implants in France. Since entering the market in late 2019, OssDsign has signed several important tenders in France leading to significantly accelerated sales during the last year.In 2019, the French health authorities decided OssDsign Cranial PSI provided high therapeutic value to patients and granted the product reimbursement on the French market. During the following years, OssDsign established an initial sales presence, secured first sales, and later gained broader